NCT04224506Withdrawn
A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis
Source: ClinicalTrials.gov · Last updated 5 Jun 2025
Reason given: Company shifted focus
Brief summary (registry, in English)
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
- Status (registry)
- Withdrawn
- Study type
- Observational
- Enrollment
- 0 (actual)
- First submitted
- 8 Jan 2020
- Start date
- 2 Mar 2020
- Primary completion date
- Mar 2030
- Lead sponsor
- ProgenaBiome
- Diseases
- Myasthenia gravis
- NCT number
- NCT04224506
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participation in any experimental drug protocol within the past 12 weeks
- Treatment with total parenteral nutrition
Other illness
- History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
Other
- Refusal to sign informed consent form
- Postoperative stoma, ostomy, or ileoanal pouch
Who the study is looking for
- Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
- May be signed by parent or legal guardian in the case of minor or adult unable to provide consent
- Male or female of all ages.
- Diagnosis of Myasthenia Gravis by a physician
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ProgenaBiome | Ventura | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.